It looks like your browser is not up to date.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

WeedMD Inc (WMD) Com NPV

Sell:0.29 CAD Buy:0.30 CAD Change: 0.01 CAD (3.33%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.29 CAD
Buy:0.30 CAD
Change: 0.01 CAD (3.33%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.29 CAD
Buy:0.30 CAD
Change: 0.01 CAD (3.33%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

WeedMD Inc. is a Canada-based company, which supplies a range of cannabis and cannabis-related products. The Company is a licensed producer of medical marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates an approximately 26,000 square foot production facility in Aylmer, Ontario. Its products include: Dried Cannabis, Cannabis Extracts and Cannabis Vaporizes. The Company provides healthcare providers and their patients with the information they need to comprehend the role medical cannabis can play in their pain-management regimen and enable them to make informed decisions regarding their overall health. In addition, the Company participates in ongoing cannabis research.

Contact details

250 Elm St
N5H 2M8
+1 (416) 5153923

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
76.45 million CAD
Shares in issue:
246.62 million
Canadian Venture Exchange
Canadian dollars

Key personnel

  • George Scorsis
    Executive Chairman of the Board, Interim Chief Executive Officer
  • Beth Carreon
    Chief Financial Officer
  • Deborah Sikkema
    Chief People Officer
  • Alexandre Sibilev
    Vice President - Quality Assurance and Global Regulatory Compliance
  • Peter Blecher
    Chief Medical Officer
  • Stephen Ng
    Chief Commercial Officer
  • Vincent Dore
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.